OFIX - Earnings call transcript Q3 2019

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Orthofix Third Quarter 2019 Earnings Results Conference Call. [Operator Instructions].

I would now like to hand the conference over to your speaker today, Mr. Mark Quick, Senior Director of Business Development and Investor Relations. Sir, please begin.

Mark Quick

good and Operator, you, afternoon, everyone. Thank the to Orthofix Third Call. Earnings XXXX Quarter Welcome

the President pass and today Officer, me harbor Serbousek. call Joining on our with are Brad. Chief Officer, Chief safe Officer, I'll start and and Brad Financial and to Doug President Rice; then incoming statements Executive Jon over Mason; Executive Chief

no statements, guidance on October XX, such those statements expectations reliance uncertainties. All and provide statements. make statements this any During of fact, matters statements plans, that involve today, historical that we about call, the earnings such our place as Investors revise today's we'll goals of do The beliefs, forward-looking We be forward-looking risks obligation cautioned including there are any update contained and are call strategies, beliefs undue to forward-looking forward-looking other statements or not to on is we and or based assurance undertake making not statements as XXXX. than any are in forward-looking our will on statements, objectives. occur. such expectations,

the Factors Some filings include under for results make could cause on materially risks we SEC December well be from the the forward-looking in in XX, Risk our that ended statements Form by the additional year us to heading the disclosed made the as as factors different actual call XX-K future. XXXX,

my documents, contact these copies office Orthofix you If of Texas. please in at need Lewisville,

U.S. XXXX release third trends, wish review accordance believe a refer in refer GAAP GAAP. financial Please various to In to our that financial of to as quarter long-term short-term addition, non-GAAP our today's reconciliations We investors to in understand measures financial announcing press on order may supplement for to today's matters non-GAAP measures. these financial U.S. results. properly these measures financial to call, with we'll our results and determined

Brad. over I'll At call this turn the to point,

Bradley Mason

he start last over to Serbousek I'd has good I to Jon and Mark, Orthofix. It products and take the great that months, it and and good what great everyone. strong by financials and been the has believe experience, set long-term to Jon a few company build publicly with skill Thanks, with is team, like afternoon, strongly company. into to right a welcoming a closely focus work

start and XXXX as call, of Doug up well performance, quarter you will for today's the observations in On the results you of will closing third I'll I'll give the for the financial by our expectations some after about and opportunities with remainder thoughts. thoughts then overview which, year. his giving depth discuss ahead more an as finish our Jon Orthofix,

that disc quarter reasons results businesses in our challenges for mixed Biologics in various third discuss the MX in detail. and the will rollout had positive and other The highlights with in cervical U.S. I

For period, expected of Therapies Bone key and delay Extremities year-over-year of net the unanticipated headwinds our the or $XXX.X for business, and company currency. Growth new quarter, currency expectations the X.X% due Spine longer-than-expected sales full we management of orders search third sales stocking for increase X.X% reported on of million, This the to our primarily disruption Fixation vacancies, representing constant short CEO fell driven a in in process. by Orthofix a

and roles of into business. and we to In three business, Spine Extremities. also the business our the The in lines the leadership you on The Biologics the the give put what R&D and the distracted Spine reorganize implemented to Biologics Sales of team and including the made and in Last delayed driver leadership these cash. most president of units as our on key end with well the growth did The order expect integration The one impacted President several Therapy marketing, around middle as Fixation transition, the In second Growth this plans into of these needed global of our rollouts. year, this their the will clinical, of X functions factors, products our consolidate business, of X, Spine for U.S., the disc. onboarding operations, and at being Kinetics R&D, sales keeping with also to very the of terminated. in decision slowed new of Spinal company. for our Spine Implants exception or product was cervical the and the Spine to of disc VP that I elevated Spine Bone regulatory a focus regulatory significant exceeded left some job the the the with quarter. product who which is starting important the the team from operations, is additional and business, expectations lead changes significantly, spine we of color consolidation, hold and plans businesses, distributors, MX-C and uncertainty each on the for eliminated including the and company new president changes were future executing sales of along MX-C addition launch of integrated and all employment nice large the

have most for require skill vacant the address the candidates recruiting and specifically begun attention. already has to experience leadership set who these the Jon needed that areas Additionally, positions

our attracting is we a in Spine XXXX. this talent are into to see priority, to recruiting impacted expect and do top we the top great to line continue process, While

much story our Extremities business is The in simpler.

have tenders We s some that our OUS large we shipping anticipated in X have time. quite business for

updated the given million currency to in-house an can uncertainty were this full now these million unable countries, for in these we we guidance hand on And for reflects orders $X inventory in geopolitical these when in our quarter, of in timing to orders numbers. products. ship, third have worth our Also, which these guidance year. removed now the had the sales the unanticipated third ship headwind of from quarter. business we the due But have orders of the $X approximately We uncertainty and

Lastly, it distraction with hires customers, some that has to the tried change postponement much led the it's a in as normally hard while as and a would have decisions new in reduce implemented. cases of been and employees been around to quantify we've uncertainty to CEO and

being a and fixable storm proposition While bit none these of and this it period, the creation. the value value a issues and Orthofix perfect process of core growth of of was are are They opportunity reflective for the in of addressed. all shareholder

next just believe said company the Jon I I rearview mirror ago, a person chapter the level. the the in take right minutes that As this is to and put few strongly to

quarter to in X.X% includes year-over-year a X.X% which line, full Spinal prior to Implants results segment Bone on Growth increased Growth this quarter year quarter's specifically. lines, fourth to growth X.X% lowered trajectory, third part, prior due, in Therapies, the in Biologics Therapies sales expectations over generated quarter, current net for product in the with sales the from currency. versus Spine, year Based million the and a to decline comparison. which implies our to in results X% have in Bone X%, difficult X.X% in XXXX which Orthofix year. our or we more to X% reported a increase sales on represents product Beginning third and Moving $XX.X constant

net fixation which constant currency Spine results year. X.X% of in compared a X.X% at In from in Fixation includes increase sales million offset reported constant X.X% or increase XX.X% Spine were These currency a constant preservation products. reported by and preservation decrease motion Spinal Implants, prior to a products, both or we $X.X motion currency driven products, our by

double-digit For the full now growth, year single-digit expect to we mid- single-digit XXXX, growth. high from down

updated previously very Spinal guidance mentioned. Fixation as of Our the sales both On MX-C U.S. reflects sales softness sales the of for the remainder disc continuing our a Spine positive I well. our to cervical and strength in continue Implant MX go the year, in note, products

for surgeons, which now full exceeded year. We has the plan have XXX trained our rollout over

reminder, there approvals. a trained is timing hospital a due surgeon to is lag As and case start the and between when they a disc implanting when typically

our cervical target. to $X plan have that us remains $X achieve in As launch of surgeons U.S. revenue continues MX--C and full today, trained we U.S. This to give million $X approximately ahead year implanted discs. our of million million will confidence

Biologics quarter the of Another compared which year. highlight to XX.X% prior was of of reported business, increase sales continuing a our performance strong the

last products in the this of high added new regions. in Based performance the year As our last our of single-digit X we performance, year several the up now contribution expectations the raised quarters, was these the to distribution the from and primarily growth. for growth solid U.S. return expect driven approximately each for from and expectation by this previous of on sales in XX%, results full sales have

of decrease over year. the business, reported constant Extremities Lastly, quarter million, in in net our or were third the in a $XX.X sales currency X.X% prior Orthofix X.X%

business, is this Given believe the this XX in to performance continue at months Extremities constant currency to we look trailing business Orthofix way basis, the the grew to On year-over-year quarterly growth. the X.X%. best assess variability its

of impact a As previous With mentioned, low that, further delay orders. down to additional growth. any adjusted currency guidance the guidance single-digit and reflect to expect shipping the our have stocking flat now possible we decrease, in from our low we single-digit

In summary, the quarter had third results. mixed

is in by on team the that I of this continued business. leadership we positive we cervical have our and performance the our MX-C mentioned quarters performance. momentum other impacted impact new of the U.S., news product is and the ahead, being disc The very addressed, in the Jon that will believe the trajectory be will and sales in very the parts MX that a While with disruption future disc issues our strong pleased good are Biologics of several negatively recruited

key our the now guidance. update take the Doug Doug? and in will financial quarter metrics through you

Douglas Rice

would and want I a when our for I team our personally tireless to his know phase team. thank to passion, of Brad, company. the our of for and say things, leadership. I I positive MX growth greater speak stage for like lines. afternoon, to with already Orthofix us lastly, for grateful He expectations I high significant by Brad's good and product we also start pushing Trinity and Jon achieve for has next the and the marketing-leading the us for made Brad our Thanks, how welcoming his other rest to impact everyone. setting also on are

miss Brad will very We much.

then measures. into discuss Moving other of on, earnings and some our results and financial net additional provide details I'll now sales our

As Brad when Extremities third a the million, constant currency also sales million. basis and on approximately included quarter XXXX. compared of quarter results total in headwinds on were $X The noted, top the up a for line reported X.X% quarter X.X% basis in of currency net $XXX.X to the mixed

additional this this provided, of representing to been full the impact prior of currency category reported sales constant from to headwinds now combined guidance million stronger currency XXXX product of net the $X in that $XXX as sales we to $XXX $X X.X% a Brad much in million. we year, have year-over-year range increase million, With our for as than expected expect be up for expect foreign and Foreign million the full X.X% X.X% now year, to impact, the or with X.X% expectations currency. of year

For of quarter, net $XXX fourth a rate be $XXX million to to sales fourth flat range reported expect the currency. we reported the to X% of implies in and to X% constant quarter which X% growth million,

in the prior period. margin to was in XXXX XX.X% the Gross XX.X% third compared quarter year

gross year and we expect margins For between the XX.X%. XXXX, to be XX% full

of XX.X% third in marketing over and an in sales the net XXXX. the XXXX, of expenses XX.X% quarter Sales increase quarter were third of

bonus continue to Biologics see due support our continued education to commission to the launch. expenses primarily to year-over-year We due training The also U.S. this commissions. programs strong in commercial MX-C has increased of and extensive the overachievement performance increase

Biologics year. for of we With the be the in the marketing full XXXX for expense year, sales project XX% continuing between revenues of and expected now in outperformance the and to remainder XX.X%

sales GAAP relative with of in associated the in from net to acquisition prior Spinal QX quarter G&A Kinetics was XXXX. expenses to expenses the the lower due XXXX, primarily down the were XX.X% third higher period XX.X% This in decrease year period. in of investments strategic

X% were higher the spending to X.X% of prior PMA due expenses process sales, primarily in down year. for from year approval last period R&D with the net quarter third the the MX-C associated regulatory

revenues of expect year X.X% XXXX. the We R&D be full spending to approximately for

the out would associated and in pending compliance the to our Medical with like Regulations Union are I XXXX deadlines. European and point efforts XXXX we of midst Device the new that

these adjusted our on of have initial QX $XXX,XXX We the related expected peers, recur many of through implementation incurred of Like going expense underlying both compliance to adjusting EBITDA are not EPS of out these the will we timing be forward. since costs XXXX. and activities, vary and will expenses depending adjusted

launch of remaining updated a Spinal respectively. reminder, acquisition-related as $XX XX-month potential million our milestone sales $XX million success to of $XX associated initial the on million And on Spinal a related to are the achievement U.S. that Based million Moving expenses, quarter upon and quarter. liability payments and the the of worldwide of have payable recognized trailing the of we $XX of $XX.X Kinetics to revenue revenue with as the we third Kinetics revenue-based long-term in charges forecast in MX-C, result, the during payment remeasurement acquisition. third the milestone we related million,

$XX.X the milestone total million of We $XX million have payments. potential accrued now

during Pursuant transactions expect terms the further $X.X settle $X payment, which benefit with with to other Moving the We the letter million approximately million we million settlement. on of a expense. our security $X cash, eNeura the of of charge other have in a eNeura expense restructured debt we to agreement received to eNeura. in recently a security concludes impairment all result associated resulting of the quarter. to already into tax for investment agreement, the $X entered investment Also, million our letter debt recognition related as

in top XX.X% $XX Adjusted This and marketing revenue, XX.X% line XXXX. that I reflects reflects from or $XX.X to $XX and accelerating from year investments primarily expect sales for primarily EBITDA as revenue This margin between down million million, well and our be mentioned. to continued as are launch XXXX. of our million. now range growth, $XX.X of reduction sales million EBITDA in the third million lower decrease decreased the or decrease down $XX commercial quarter reflected MX-C of to the the $XX million gross for previous from We that of adjusted expectations the

quarter the as associated tax. domestication, of purposes. to taxes before impacted provision by taxes income GAAP of the negative income income milestones, had same XXXX, acquisition-related We tax quarter compared expenses significantly period achieving resulted with largely XX% was expense the net GAAP tax turning deductible of certain period to benefit tax for a we the is benefits not of before XXXX. The which tax Kinetics in In for recognized of income loss of in related credit. our Now a tax of income X% increase which the the Spinal this likelihood in to for same

EPS a compared $X.XX XXXX. to the For third per diluted using when for share third to and per MX-C a tax was to of third the normalizing U.S. non-GAAP long-term GAAP of items quarter as effective reported the XXXX, loss rate, tax of After The adjusted third $X.XX the share for we quarter investments adjusting the quarter was for quarter the majority certain for $X.XX in in XXXX decrease due XXXX. the launch. $X.XX compared

and adjusted For the $X.XX, we between of $X.XX earnings $X.XX be full to year down expect XXXX, share now our per previous expectations from $X.XX. will

to EPS $X.XX $X.XX. to in expect quarter, the we fourth adjusted the be of For range

XX DSOs, days up XXXX Spine on sheet of at at end third third in the the of balance Global XXXX, XXXX. second quarter highlights. at or the days certain of from outstanding, of the to to days segment. due quarter collections quarter from end XX and our the primarily This the the is were increase end sales Days timing XX Moving the

to coming and temporary this increase quarters. be improve We to expect in the

from quarter million at X.Xx XXXX the turns third in were the of cash in third inventory compared quarter. XXXX. the in due increases Cash roughly and million, the our the XXXX down quarter million to end the of equivalents from to line operations was other quarter Cash primarily Our the that at at million restricted for quarter initiatives. of end and quarter inventory investments growth at totaled end cash $XX.X $XX.X previous third $XX.X third capital $XX.X the working and flow the flat top support

of year million, in disc. in for due Capital $X.X capacity cervical $XX the infrastructure MX the manufacturing expect million $XX million. to expenditures million expansion We $XX artificial million investments our now prior global capital and the XXXX quarter from in were to to $X.X from expenditures million down $XX IT primarily to up

subtracting cash flow, to we million in the $X.X flow was by expenditures, taking and during year. $XX.X million cash capital calculate which compared the Free from quarter operations prior

with we from our also our our to note as borrowing improved previously the of well new renewal to subsequent previous happy Finally, XXXX and as tighter as flexibility spreads operating I'm environment credit facility be million credit to to covenants. provides that, our We the $XXX domestication Delaware. our updated million as announced upsizes needed to were agreement additional approaching reflect This today, of revolver growth from XXXX our facility. $XXX well expiration and which financial updated

that, now With I will Jon. over to it turn

Jon Serbousek

start the Thanks, and the to for Brad, stakeholders Doug. first productive. balance infrastructure, months. over the to the rest job generation a deal by team and the with foundation. I very employees here about thanking I've time With the great internal me execute to our the first thing is Orthofix months is in a few team, clear has robust have cash leadership external controls spent sheet, very company. commercially. I of internal believe my few business is Doug, and clean great done solid programs, Orthofix and flow a last compliance want Board and One strong been building warm welcome considerable learned positioned well the at

experience I for commercial opportunity and my based spine, execution biologics general, see In in great ahead my space, driving Orthofix. opinion, on medical device

of and, course, We cell-based and positions artificial external market bone disc in technology obvious well-defined leadership and have replacement. fixation, allografts, some stimulation, growth

have next I years. growth canvas assets We Needless upon. to over for to several have a believe white great undoubtedly say, build we many the

focused term, my on be fourth team spine long-term and know strategy to Extremities and to I'll will a secure business strengthening In to well the you those priorities. execution our next exciting quarter I very objectives. the I sharing I'm on leadership story, priorities to analysts our work months guidance plans while our on with investors potential short needs on task to and within our to for in assessing After growth. My the shareholders, position update which the XXXX leadership business be forward to as and and with our set short-term business meeting will as follow call. that, one. look Moving

it remarks. for turn back Brad his I'll to closing that, With

Bradley Mason

team have tirelessly Jon great a a who the at and be future that any an developing a last On good you, for since to share been want Jon. our patients' much with this in last enjoyed year. very Jon's all Thanks, particularly create stakeholders to times. note, and interactions I thoughts, and consulting accelerating personal to I've and my with role I has with to while and both is I look will amazing shareholders assisting help rewarding world X.X leadership how around my growth. can my Orthofix forward shareholders, our opportunity products over confident of want to am of the improve tell the lives my the Orthofix, privilege you employees and and worked the financial analysts. all to thank next for in the difficult the way company serve foundation I that Orthofix honor It through I years business

to up that, With we're for open lines the ready operator, questions.

Operator

Instructions]. [Operator

line Craig Cantor from the first of or Bijou comes comment Fitzgerald. question Our from

Craig Bijou

with start with enjoyed good your working endeavors, of and I and just you luck Brad, me quick future a to you. Let wish

Bradley Mason

me. for appreciate Thank you, Same I Craig. that.

Craig Bijou

term that may I to things for and strategy, the lot me And Obviously, on. coming the integration still any given get the or Spine struggling high And early, strategy, integration picture, overall Brad a called change a Jon. are term? out, near then some and just longer X the thoughts is change With of is -- any a in want at ones it the of perspective, business? of just the an sense other the and of little in in level. so either be let But a Jon there start Biologics in bigger from delays little bit, strong pieces a the of going just

Jon Serbousek

Craig, mode. be this you still I'm thanks well. gathering the here for will it's number this forward guidance but at for But I quarter been It's data-gathering really point a on the it'd I've though. basically stage, that in that for think data, I premature strategic of and really to to to on going weeks, time. question. providing me call, look the give fourth At

Craig Bijou

specifically. Okay. bit a more And maybe little

to You some guys being distributors. onboard able talked about not

mean the issues some one questions is the have investors any going confidence during obviously, that of -- that the don't -- are I saw get you of to guys the you have So that that worse. quarter

you steps what guys have if the some little have things plan you do, so that are get quarter we just don't sense maybe to either So you that worse the and can that outline during you a of of better this? or guys ensure can done, rebound from to doing

Jon Serbousek

There's just this information in doing getting my gather time and direction. if is or strategic do, nothing basically, I'm is see spending the short them the business in in and any the form. things it. understanding that for there's Craig, unwinding and way, I can that's And I I more I'm the term as granular basically What more learning Jon. shape

that. But that's no, handling also, experience stance. just in there's Street. to based a the on about lot on learn. We're to on But on nothing so that there's And just day-to-day basis next The more a business my worry

Craig Bijou

Doug if one the Okay. squeeze guidance. maybe obviously sales down one then you brought in. quickly, guys And EBITDA, On last for could I

million $XX was the midpoint. it think the midpoint. at million at came down EBITDA I $X

about your But normal maybe came contribution? at why any a little reason it other down bit EBITDA just higher than bit think a So, some talked Doug, I you little investment. rate

Douglas Rice

a it's good Craig, Yes. question.

of before, like and marketing out we're in the things out investing ahead revenue on we stated As sales MX.

U.S. of logistics, sales, MX. launch the ramping So trainers investing comes education, when success on to the of are and initial up in based it the we

that think looking that you're seeing the some in flow-through at. of I you're So

In NASS a conference. great addition, we had

and as reflective spending of flows the through QX see end-of-the-year You'll that, well. that guidance

Operator

the or Denhoy Raj comment next from line Our of question comes from Jefferies.

Anthony Petrone

terms I'll is with Brad and was to forward look X Extremities, for second have working few actually back questions, quarter. also pushout congratulations questions extra Doug, for day you. half then that, to going of want the Great. then and to Anthony and have company, million, does This Raj, of then -- my in XXXX. any we your a selling reiterate in a $X Doug, the guidance I with companies new second of handful Brad on revision in to the I'm confirm coming with Jon. to housekeeping in in in start to that and other the not at just point the Jon and the I'll include and to role an And alluded benefit that for

extra just there selling confirm, from so, I if day? that a to what benefit So the was want was selling in quarter? And contribution day the

Douglas Rice

extremity, to $X we with taken we've the the really regards Anthony, of out quarter. the guidance year. remainder of you and on are regards for it and not With days selling within a to That's focused selling million, days, workdays have amount, Right. correct. the the

we consider that focus, driver would a long-term our I material Given this don't think quarter.

Anthony Petrone

The the the Street, $X the OpEx I I was of, And in guide, about just miss And Brad top the guess, line just million. is or terms looking estimates $XX the in of Okay. guess million. Jon, to relative midpoint, our at

see certainly XQ are to continue that math headwinds. going XQ to and So suggests

would on that additional much how And really in versus of helpful. customers? so fronts any side is of vacancies those be the hesitation color on sales And

Bradley Mason

Sure, Anthony. It's Brad. hard to It's quantify.

you don't hit term, then impact. I that and that we I leadership a Jon's term. to significant will in when Spine clear, over was that recover the had And in leadership pretty around some things, that Long think a changes. particularly some, in it's of to want to lot of from combination we experience uncertainty a summer, -- that spine. with hit us, underestimate vacancy one the short be the But

VP Sales our also lost We in spine. of

translates was one So sales is It be could It some that distributors. It a be number as that of down, Certainly, can it can the things. be customers. of be management could concerned. coming of the distributors on, or bringing are we bigger were anticipated onboarding onboard. in they either impacts previously in larger that these either what delayed, versus that delayed -- we

those All there's one nothing We've that And our think we're going want core fill. broken business. investors fixable. things vacancies take got I I are our some of in away is to management that to the note

I think get those I recruit talent. is and we will is these those then network Jon what time, as -- positioned some people spine. to beyond extraordinarily some. all over well in well be think, is fixed His I mine And as top onboard, think new of things

Anthony Petrone

be filled? how then actual slots a just [Technical in number And that sort have And And just to specific a on is many would just I'll Difficulty] follow-up of force the there, Brad, months? be six. sales turnover there few was sustained the past

Bradley Mason

terms out numbers nor hand, way. of the think them have off distribution. don't that track do I and But I Yes. of there's I Anthony, nothing there is those in that of turnover quite ordinary

Anthony Petrone

you last MX. sounds did -- $XXX,XXX $X.X would was like last for then $XXX,XXX And the versus me the that quarter. and It be on million, one

So clearly, XXX big in momentum, surgeons. the exceeded training and you on guys

mentioned think I I XXXX. would Brad, the believe active of for about implanters, the -- last into quarter, those that target heading year, I guess, but you XXX be XXX was

a that, many now that so MX you is into heading active implanters XXXX? that bit number And you expect when -- how upsized,

Bradley Mason

Anthony. Yes, yes. Absolutely,

the So surgeons. training here's thing the about

for coming -- of of a requests lot have training. variety a have we we So in

Some a surgeons cases. will do of lot these of

these of It depends. months. X a or will and cases, every all few X surgeons Some a do some will be case

very, does mentioned is have be take with for in own it going thing be Most It can that loading, time hospitals. and careful very are So Also, that. a and that's these train, surgeons of practice make their are ramp-up insurance time we're once belief requested. their coverage. good other in lag It case in things and own all is -- There's to the the previously, products. can factor there's trained, as I they like -- lag surgeons the we changes products. those mentioned adopt training with Jon a time, of how with surgeon about the kind

or And want to to few so see so for cases another they're it X, and case period follow of on. a going time a then

a surgeons. a up So -- for most little it while takes little to ramp bit

the the are number surgeons, we're while of a where So will plan with of is for still year, our date we our what had to the we're overall what compared that accelerating. in sales steady we be XXX was. even and with to that but we happy ahead ramp happy And number very expect planned very good and

Operator

line Our the comment or from BTIG. Zimmerman next comes of Ryan question from

Ryan Zimmerman

Great. a forward with talk dynamics you. want Brad, in look quarter. about some I well. I pleasure with to the to you the it's been Jon, working as work of to

asking. sounds if distributor surgeon to those of about coming the impact MX are momentum XXXX the those because is But considering should were then what these coming that's following And onboard? from now recall, dynamic seeing dynamics, that just the you aren't were assurance we like you're On relative that other for there with in you any distributors, -- onboard predicated It up just on well. that people delays Brad, I MX. some with have with think training. sales is that distributors going how

Bradley Mason

No. MX we negative and just are Yes. beginning. have really cases it's is impact sales. Jon distributors there a Those well. momentum speak but from in the any can number on MX continue No. And will as those selling to, distributors this expect to of don't I

nice in think MX. from nothing snowball we're the plans that I to regards for our a or XXXX effect expectations threatens MX, to going get but

of know on the the the is that we we job said staying focused And really because a #X done launch. very I As XXXX. team that, remarks, my nice growth in that have going driving is has -- into MX prepared driver

Ryan Zimmerman

Right, some into right. growth And market I in of us of then It's days the to growth XXXX? of bit. do that out hard like improve these how nice growth? a year. bone along stimulation those coming little last look had And maybe really moderate mean, level you refresh terms lines, growth what's You

can you market's where do kind that? to improve of that us So what just And help understand at?

Bradley Mason

so that's business that. over not we've a -- years. is very for significant a couple far excess pretty that Obviously, can to But the a can't Yes, rate, said probably it's us. range that X is I've good, that's guess. happen annual growth last it's marketplace. for And absolutely. growth that's in a expect That's procedure years -- I'm just now in said we And forever really of X.X%, a what important in been I X, rate long X grown compound run that. question, mature -- growth a confirm We've the average great X% we've at Ryan. pretty of years, had guessing

ASP So growth I outgrowing face growth to -- by be market back our the ASP procedure even think the we'd for rates, procedure some in come outgrowing we'd considerable share, declines still potential us, we or rate. if be with of by ASPs, declines, volumes

my X%, how very own the growth, I to X% in done obviously, if X% in Jon's well, leave market. would thoughts we this that's But -- we to can I that terms hands. will well market, think we've the just and his we'll into that have X%, expect think you date, opinion. do as Jon What So continue. about think of that's X%, in business and

We there. very, have very distribution a strong

has have did added is previously loss, but of was has therapies. leadership little what impact of sales we We business talent. and Spine on bone a well, the that bit a with us as was there -- there recover our growth focused strong his And some That was president none that as changed. specialty. will well What

Ryan Zimmerman

Okay. for then question Doug. last And

a mentioned a on timing I was Is tax from, eNeura. less of think, think that that? that I impairment million do open-ended. When expect coming benefit, the your you of there Doug? time benefit think the $X should investment You we about

Douglas Rice

expect perspective, From benefit realize tax cash that rate. XXXX we We our and when our GAAP to next our file that return situation. up we'll benefit settle XXXX a year tax

Ryan Zimmerman

Okay.

in So it. 'XX, got sometime

Operator

Securities. Turkaly Dave from or comes line JMP question next Our the of comment from

David Turkaly

you busy chance And, going Brad, I to a here get time you're the while. to some hope more Jon, be looks spend for like surfing.

good still? talked So there in of pricing in on is overall happening Or to I be board. comment bit a would that any on decline call, accelerating a was about the but Spine, bit. potentially wondering market? you spine -- what Last ASP your have we

Bradley Mason

Yes.

Our view is it's no worse than normal.

in of the pressure. probably in fact, a little ASP terms better the quarter In bit

no, an previous pressure not So, kind seeing ASP patterns. in we're over increase of

David Turkaly

do since curious, the of new you you're in mentioned and gotten in bag? And those, if it. Got product curious distributors bring positions. trying vacant I'm to that new reps, have the more people I'm you've outside now two to out hire you need that launched? approved there MX you

Bradley Mason

absolutely. Absolutely,

vacant us. opportunity just a of lot areas, out pure of lot there, for have white a space We that's

we We lot in coverage of area have for a the improvement will -- the sure. in U.S. have we for

Jon Serbousek

have this topic, On MX. to us distributors of more Dave, opportunities MX. want with now, have distributors leverage them carry move to they for And to we products to get basically with the looking coming have additional those is we because for in that, our that more Jon. to

in for us now. So right it's to position a be good positive

David Turkaly

Got it. Last one.

colors how were You -- you? or the new understand, guess them in imagine some I to I'm many any or mostly And there's mentioned MX? percentage are of past opportunities XXX in to people cross-selling, customers new surgeons. Any for prior trying there, Orthofix what but these for Orthofix

Bradley Mason

good a That's question.

customers couldn't is existing of mix my can what and the I you new a it's tell of think but mix Dave, off I that up. top we head, follow customers.

Operator

from or Our Ladenburg the Thalmann. line comes of comment next Cohen question from Jeffrey

Jeffrey Cohen

you wish best. your all and the Brad, service, thanks for

Bradley Mason

Thank you, Jeff.

Jeffrey Cohen

as And, I well. you, you Jon, the welcome best all wish I and

filled, like there's as sounds commentary western What top on but can that fair on remedy QX the you I the spillover I may would be some that roles calendar a end but know into necessarily and you bit the of then integration XXXX. us of year. sound expect that if -- and that a could year as backlog? to up expand as line would your distributors spills far give of follow some of this you of upon for So to over sense some amount portion QX? Not as through be into by how the as those it looking far new guidance, a there's want as like little to be you far stated address previous that on impacted, a delays, the impact

Jon Serbousek

you can't pull The always for to the basically push, tapping a talent. just looking Jeff, work is best for can interim, the we've best of we viable in, hiring in looking the really thanks a from trying fill also we're process, talent made a to decisions network coming and forward, distribution the got question. we so those -- far line and I'm And haven't only sales, as candidates number time my not that as opportunities, the roles. those In and at but it's in coming yet. but

premature tell me that, time role. you priority it's to So for into the be it a one on but would basically the frame coming

of for And deal the on That's we'll as not great talent that ongoing spend the a be we're only to part as bringing the so well. activity talent also of organization, but time, distribution with an well. looking

Jeffrey Cohen

continent as you this $X it. Could us? a particular Got could far quarter Okay. from you come upon from the impacts or expand ramifications. for that a that color as million territory us give Should

Bradley Mason

and that business on. been in off countries of been be have We're us, have Libya, the good situation couple those traditionally -- volatile for geopolitical can Lanka, some a There's talking countries. and Sri Yes. is

had to orders tenders. the while from those through, quarter more expectations, actually, than ago, so And we come a tenders for those

case. out haven't orders, these are These lot We areas. of are business -- that X These can But them the our we deal it the that -- that all are can countries be that's products a be on there's and patients have, the But be required over we product, things in more got long it good and our product. purchase with can documentation And happen need little the the our for volatile. need who countries in to that us. traditionally, in more countries. some haul, importantly, a particular just patients fact, of need We got in get there this those orders. just those

Jon Serbousek

to we at how want those accounts. just is I I'm sure, Brad basically about we this Jon, to I -- look Jeff, how and that, how that talked Jeffrey, basically add we --

going side, so those loading choppiness be thing don't to going not to we do. going forward. we're into forecast forward. any the going so think And them we We're off to these numbers a that's have And prudent the in leave

Jeffrey Cohen

it. Got

portfolio your could lines further Okay. as Biologics. to as or as product lastly, as will, as you show doing you're Biologics color, compared little far acquisitions you DBM expect any And the as if trends a that on developments the is Trinity? further then portfolio, you far within as far seeing new if And how

Bradley Mason

gain marketplace. we the is now do DBM the bring year-over-year, percent or year. if somebody the traction in Trinity. It has cell-based -- is after is where the ELITE situation continued reflected first out our sell as released if the and XX-plus #X that's see that's earlier what our of, forward, but don't will numbers. price the allograft Trinity based that's in We still that customer to DBM on standard growth the year this only, gold a what we And in quarter And you super most really and and is year all a choice. that we Trinity after there, year

Operator

Instructions]. [Operator

Sidoti. comes from from or Sidoti the comment next Jim of Our line question

James Sidoti

Can you hear me?

Bradley Mason

Yes, we can, Jim.

James Sidoti

full you just quarter margin, and Great. -- for metrics to the fourth Doug, numbers gave and wanted sales or numbers? marketing, R&D year those gross were

Douglas Rice

full gave year guidance Jim. I in script, my

James Sidoti

the the up want sure Or business Right. orders up Is related And is ahead understood right. more million. to inventory MX? of inventory and just those tender not -- related about that. Okay. $X I to that that shipping? I building to All the is the make for in quarter, Extremities

Douglas Rice

the beginning the of $X understand question, what? million the didn't on I

James Sidoti

inventory didn't Why go up in the Right. quarter?

Douglas Rice

that, launching as are out well. of spine couple Number of one, Yes. it's just Again, product MX. We're some getting well on see. and I ahead a out lines based anticipated getting reasons. that Oh, ahead we of as rollout the of we're as

James Sidoti

in Right. put do sets instrument field you that? in need for the And out to

Bradley Mason

putting go up grows, we'll anticipate But utilized. growth. Well, out in can instrument they're yes, try our sets, ultimately the instrument overall, We how business general, put would where instrument be we we as as efficient to metals those support sets to more as efficiently and sets. with

James Sidoti

there And now? can instrument of sets how a you give rough us idea many out are

Bradley Mason

be Jim. That a would tough one,

of We sets types hundreds and different there. have of hundreds out

James Sidoti

the meant I MX. specifically for

Bradley Mason

for wouldn't give We competitive purposes. Oh. information, that just

James Sidoti

I you is it's Brad, time think do you're doing. at think really least the luck Well, right. this And Good second time? goodbye. All in this what goodbye Okay. saying

Bradley Mason

You never well. over relationship appreciated you wish been Jim. to and best and as our grateful never, it I've the have say for all the years

James Sidoti

thinking it's about I'm saying right. least Right, time the at it, goodbye. third

So good you do. whatever with luck

Bradley Mason

Yes.

Jim. Thanks, bet. You

Operator

queue in questions this additional no the showing for any to management to back closing at I'm over turn time. conference like the remarks. I'd

Bradley Mason

Take bid everybody, today, wish and Operator, farewell, Thank best. you all I Yes. thanks, you and the and for care. us I joining you,

Operator

Ladies today's thank conference. you concludes This and in for participating gentlemen, the program.

now disconnect. You a day. have Everyone, may wonderful

Orthofix Medical (OFIX) 28 Oct 192019 Q3 Earnings call transcript